Related Experiment Video
Updated: Mar 30, 2026

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
Published on: February 18, 2014
Exploration of gated ligand binding recognizes an allosteric site for blocking FABP4-protein interaction
Yan Li1, Xiang Li2, Zigang Dong1
1The Hormel Institute, University of Minnesota, Austin Minnesota 55912, USA. yanli0208@hi.umn.edu zgdong@hi.umn.edu.
Abstract:
Fatty acid binding protein 4 (FABP4), reversibly binding to fatty acids and other lipids with high affinities, is a potential target for treatment of cancers. The binding site of FABP4 is buried in an interior cavity and thereby ligand binding/unbinding is coupled with opening/closing of FABP4. It is a difficult task both experimentally and computationally to illuminate the entry or exit pathway, especially with the conformational gating. In this report we combine extensive computer simulations, clustering analysis, and the Markov state model to investigate the binding mechanism of FABP4 and troglitazone. Our simulations capture spontaneous binding and unbinding events as well as the conformational transition of FABP4 between the open and closed states. An allosteric binding site on the protein surface is recognized for the development of novel FABP4 inhibitors. The binding affinity is calculated and compared with the experimental value. The kinetic analysis suggests that ligand residence on the protein surface may delay the binding process. Overall, our results provide a comprehensive picture of ligand diffusion on the protein surface, ligand migration into the buried cavity, and the conformational change of FABP4 at an atomic level.
Insights
Fatty acid binding protein 4 (FABP4) binding mechanisms were revealed using simulations. Researchers identified an allosteric site for novel cancer drug development targeting FABP4.
Area of Science:
- Biochemistry
- Computational Biology
- Pharmacology
Background:
- Fatty acid binding protein 4 (FABP4) binds lipids and is a cancer treatment target.
- FABP4's buried binding site and conformational gating complicate ligand binding studies.
Purpose of the Study:
- To investigate the binding mechanism of FABP4 and troglitazone.
- To understand ligand entry/exit pathways and conformational changes in FABP4.
- To identify potential allosteric sites for novel inhibitor development.
Main Methods:
- Extensive computer simulations
- Clustering analysis
- Markov state model (MSM) to analyze FABP4-troglitazone interactions.
Main Results:
- Simulations captured spontaneous binding/unbinding and FABP4's open/closed conformational states.
- An allosteric binding site on the protein surface was identified.
- Calculated binding affinity matched experimental values; kinetic analysis indicated surface ligand residence may delay binding.
Conclusions:
- The study provides an atomic-level understanding of FABP4 ligand binding, including diffusion, migration, and conformational changes.
- Identified allosteric site offers a new strategy for developing FABP4-targeted cancer therapies.
- Computational methods combined with MSM are effective for studying complex ligand-protein interactions.
Related Concept Videos
Ligand Binding and Linkage
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Allosteric Regulation
Allosteric Regulation
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization

